Literature DB >> 8415406

Substituted xanthones as selective and reversible monoamine oxidase A (MAO-A) inhibitors.

U Thull1, S Kneubühler, B Testa, M F Borges, M M Pinto.   

Abstract

1,3-Dihydroxy-2-methylxanthone (X1), its 4-chloro and 4-bromo derivatives (X1-Cl and X1-Br), and 1,3-dihydroxy-4-methylxanthone were investigated for their inhibition activities toward MAO. A hyperbolic function was derived to fit the data and to calculate IC50 values. The compounds proved to be reversible and selective inhibitors of MAO-A, with X1 displaying the highest activity (IC50 = 3.7 microM).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8415406     DOI: 10.1023/a:1018924503552

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  A rapid spectrophotometric assay of mono-amine oxidase based on the rate of disappearance of kynuramine.

Authors:  H WEISSBACH; T E SMITH; J W DALY; B WITKOP; S UDENFRIEND
Journal:  J Biol Chem       Date:  1960-04       Impact factor: 5.157

Review 2.  Molecular genetics of the monoamine oxidases.

Authors:  Y P Hsu; J F Powell; K B Sims; X O Breakefield
Journal:  J Neurochem       Date:  1989-07       Impact factor: 5.372

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Chemistry and pharmacology of Gentiana lactea.

Authors:  D Schaufelberger; K Hostettmann
Journal:  Planta Med       Date:  1988-06       Impact factor: 3.352

5.  Ethoxyresorufin O-deethylase activity in rat brain subcellular fractions.

Authors:  B Walther; J F Ghersi-Egea; Z Jayyosi; A Minn; G Siest
Journal:  Neurosci Lett       Date:  1987-04-23       Impact factor: 3.046

6.  The metabolism of rat brain mitochondria. Preparation and characterization.

Authors:  J B Clark; W J Nicklas
Journal:  J Biol Chem       Date:  1970-09-25       Impact factor: 5.157

7.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

8.  Inhibition of type A and type B monoamine oxidases by naturally occurring xanthones.

Authors:  O Suzuki; Y Katsumata; M Oya; V M Chari; B Vermes; H Wagner; K Hostettmann
Journal:  Planta Med       Date:  1981-05       Impact factor: 3.352

9.  Inhibition of type A and type B monoamine oxidase by isogentisin and its 3-O-glucoside.

Authors:  O Suzuki; Y Katsumata; M Oya; V M Chari; R Klapfenberger; H Wagner; K Hostettmann
Journal:  Planta Med       Date:  1980-05       Impact factor: 3.352

Review 10.  Biochemistry and pharmacology of moclobemide, a prototype RIMA.

Authors:  W Haefely; W P Burkard; A M Cesura; R Kettler; H P Lorez; J R Martin; J G Richards; R Scherschlicht; M Da Prada
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

  10 in total
  1 in total

1.  Monoamine oxidase inhibitor properties of some benzazoles: structure-activity relationships.

Authors:  T Grandi; F Sparatore; C Gnerre; P Crivori; P A Carrupt; B Testa
Journal:  AAPS PharmSci       Date:  1999
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.